Behavioral InterventionITPNCT07042477
Integrated Telemedicine Program Evaluation
A study testing Integrated Telemedicine Program in people with Behavioral Intervention and Emergency Department Visits, run by Geisinger Clinic at 1 site in United States.
Trial summary
This project will evaluate a virtual, on-demand telemedicine program for High emergency department (ED) utilizers with comorbid physical health conditions and behavioral health correlates. Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- Behavioral Intervention, Emergency Department Visits, Telemedicine
- What is being tested?
- Integrated Telemedicine Program
- Type of treatment
- Lifestyle or therapy programme
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 1,484 participants
- Where
- 1 siteUnited States
- Study dates
- 18 Jun 2025to 30 Apr 2026
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- 18+ years old
- 4+ Geisinger ED visits in the last 6 months
- Geisinger Health Plan (GHP) insurance member
- Has a Geisinger PCP
- Patient is being seen at one of the following facilities: Geisinger Lewistown Hospital, Geisinger Medical Center, Geisinger Bloomsburg Hospital, Geisinger Jersey Shore Hospital, Geisinger Community Medical Hospital, Geisinger Wyoming Valley, Geisinger Medical Center Muncy, Geisinger Shamokin Ach Hospital, Geisinger South Wilkes Barre
Who cannot join
- Patient being seen in departments determined ineligible by the study team
- Patient is diagnosed with alcohol and substance-related disorders
- Patient is going to receive inpatient care
- Patient is coded in the ED as Level 1 (i.e., seeking life-saving measures)
- Patient has an Intellectual Disability or Traumatic Brain Injury
- Patient is actively seeing a BH provider
Trial locations and contacts
1 site in 1 country.
About this study
Official title: An Integrated, Virtual and On-Demand Solution to Avoid ED Utilization
This project will evaluate a virtual, on-demand telemedicine program for High emergency department (ED) utilizers with comorbid physical health conditions and behavioral health correlates. Researchers will randomize patients to have either full access to the full intervention (treatment group) or to receive only standard care (control group). Analyses will be intent-to-treat. The primary outcome is the number of ED visits 120 days after the first Best Practice Alert (BPA) firing.
The research team plans to enroll 3200 patients in this study. However, randomization may end due to system constraints on December 31, 2025 before reaching that target. This sample provides 80% power to detect a 35% relative reduction in ED utilization using a two-tailed test with an alpha of .15, assuming 40% compliance with the program.
- Being tested
- Integrated Telemedicine Program
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Integrated Telemedicine ProgramBehavioural
The integrated telemedicine program is short-term bridge support provided by a virtually accessible team, including a behavioral health provider (Health Psychologist or Licensed Clinical Social Worker [LCSW]) and Community Health Worker (CHW). Once stabilized, members transition from bridge support to ongoing care with a Geisinger Health System Primary Care Provider and Behavioral Health Provider.
| Study group | Role | What they receive |
|---|---|---|
| Integrated Telemedicine Program | Experimental | Patients will be invited to participate in the integrated telemedicine program through text, email, and/or phone calls. Receives: Behavioral: Integrated Telemedicine Program |
| Control | No intervention | Patients will receive only standard care and will receive no invitation to participate in the integrated telemedicine program. |
What is being measured
The primary outcome is the main question the study is designed to answer.
Emergency Department Visits
Number of emergency department visits
Measured: within 120 days of the initial BPA firing
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted29 Jun 2025
- Study start18 Jun 2025
- Primary completion30 Apr 2026
- Study completion30 Apr 2026
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Behavioral InterventionStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Health services research
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Enrolment
- 1,484 participants (actual)
Sponsor and investigators
- Lead sponsor
- Geisinger Clinic
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Amir Goren, Geisinger Clinic
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07042477
- Sponsor's protocol ID
- 2024-0554
- Acronym
- ITP
- Status last verified
- Jun 2026
- First submitted
- 18 Jun 2025
- Last updated
- 23 Jun 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
Study at a glance
From the registry record, last updated by the sponsor on 23 Jun 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- An Integrated, Virtual and On-Demand Solution to Avoid ED Utilization
- ClinicalTrials.gov ID
- NCT07042477
- Acronym / sponsor ID
- ITP / 2024-0554
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 1,484 participants (actual)
- Lead sponsor
- Geisinger ClinicUniversity, hospital or other
- Study start
- 18 Jun 2025 (actual)
- Primary completion
- 30 Apr 2026 (actual)
- Study completion
- 30 Apr 2026 (actual)
- First posted
- 29 Jun 2025 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This project will evaluate a virtual, on-demand telemedicine program for High emergency department (ED) utilizers with comorbid physical health conditions and behavioral health correlates. Researchers will randomize patients to have either full access to the full intervention (treatment group) or to receive only standard care (control group). Analyses will be intent-to-treat. The primary outcome is the number of ED visits 120 days after the first Best Practice Alert (BPA) firing.
The research team plans to enroll 3200 patients in this study. However, randomization may end due to system constraints on December 31, 2025 before reaching that target. This sample provides 80% power to detect a 35% relative reduction in ED utilization using a two-tailed test with an alpha of .15, assuming 40% compliance with the program.
Study design
- Primary purpose
- Health services research
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Integrated Telemedicine Program | Experimental | Behavioral: Integrated Telemedicine ProgramPatients will be invited to participate in the integrated telemedicine program through text, email, and/or phone calls. |
| Control | No intervention | –Patients will receive only standard care and will receive no invitation to participate in the integrated telemedicine program. |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (5 listed)
- 18+ years old
- 4+ Geisinger ED visits in the last 6 months
- Geisinger Health Plan (GHP) insurance member
- Has a Geisinger PCP
- Patient is being seen at one of the following facilities: Geisinger Lewistown Hospital, Geisinger Medical Center, Geisinger Bloomsburg Hospital, Geisinger Jersey Shore Hospital, Geisinger Community Medical Hospital, Geisinger Wyoming Valley, Geisinger Medical Center Muncy, Geisinger Shamokin Ach Hospital, Geisinger South Wilkes Barre
Key exclusion criteria (6 listed)
- Patient being seen in departments determined ineligible by the study team
- Patient is diagnosed with alcohol and substance-related disorders
- Patient is going to receive inpatient care
- Patient is coded in the ED as Level 1 (i.e., seeking life-saving measures)
- Patient has an Intellectual Disability or Traumatic Brain Injury
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Integrated Telemedicine ProgramThe integrated telemedicine program is short-term bridge support provided by a virtually accessible team, including a behavioral health provider (Health Psychologist or Licensed Clinical Social Worker [LCSW]) and Community Health Worker (CHW). Once stabilized, members transition from bridge support to ongoing care with a Geisinger Health System Primary Care Provider and Behavioral Health Provider. | Behavioural | Integrated Telemedicine Program |
Primary outcome
Emergency Department Visits
Time frame: within 120 days of the initial BPA firing
Number of emergency department visits
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 23 Jun 2026.
Related trials for Behavioral Intervention
Not yet recruiting
Guided Physical Activity Counseling: A Pilot Study
Physical Activity, Fitness Tracker
Not yet recruitingPhase 1
Mirogabalin Plus EBMP for IC/BPS
Bladder Pain Syndrome, Educational Behavioral Intervention
Not yet recruiting
Impact of Appointment Reminder Strategies on Smoking Cessation Clinic Attendance
Behavioral Intervention, Nicotine Addiction
Not yet recruitingPhase 1
Efficacy and Safety of Pregabalin Combined With Educational and Behavioral Intervention for Bladder Pain Syndrome/Interstitial Cystitis
Bladder Pain Syndrome, Pregabalin
Not yet recruiting
Effectiveness of an AI-Enabled Mobile Intervention on Lifestyle Behaviors and Maternal-Infant Health
Mobile Health Apps, Lifestyle Intervention
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Integrated Telemedicine Program in people with Behavioral Intervention and Emergency Department Visits, run by Geisinger Clinic at 1 site in United States.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 5 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 23 Jun 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Emergency Department Visits (time frame: within 120 days of the initial BPA firing). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 23 Jun 2026.